Literature DB >> 19544559

Synergistic effect of HLA class II loci and cytokine gene polymorphisms on the risk of gastric cancer in Japanese patients with Helicobacter pylori infection.

Takashi Ando1, Takeshi Ishikawa, Haruki Kato, Norimasa Yoshida, Yuji Naito, Satoshi Kokura, Nobuaki Yagi, Tomohisa Takagi, Osamu Handa, Jo Kitawaki, Naoto Nakamura, Goji Hasegawa, Michiaki Fukui, Eiko Imamoto, Chie Nakamura, Hirokazu Oyamada, Yutaka Isozaki, Naohito Matsumoto, Yasuyuki Nagao, Mika Okita, Yoshihiro Nakajima, Manabu Kurokawa, Masafumi Nukina, Mitsuhiro Ohta, Shigeto Mizuno, Masakazu Ogata, Hiroshi Obayashi, Hyohun Park, Yoshihiro Kitagawa, Koji Nakano, Toshikazu Yoshikawa.   

Abstract

It has been reported that polymorphisms of human leukocyte antigen (HLA) genes and several cytokine genes are associated with an increased risk of developing gastric cancer (GC). However, the results of studies from different geographic regions, ethnic groups and study groups are inconsistent. The aim of this study was to evaluate the influence of H. pylori infection and host genetic factors on GC susceptibility in Japanese patients with GC. We analyzed genotypes for HLA class I and II, tumor necrosis factor alpha, interleukin (IL)-1beta, IL-1 receptor, IL-4, IL-4Ralpha and IL-10 in 330 H. pylori-infected noncardia patients with GC and 190 H. pylori-infected nonulcer dyspeptic controls. Haplotype analyses indicated that the frequencies of the HLA DRB1*0405 and DQB1*0401 alleles were increased in the patients with intestinal-type GC when compared with controls (both DRB1*0405 and DQB1*0401: p = 0.015, OR = 1.57, 95% CI = 1.09-2.26), but the changes were not statistically significant after correction for multiple comparisons. None of the cytokine gene polymorphisms were associated with GC susceptibility, whether patients with GC were analyzed as a group according to the histological subtype. Of interest was the comparison of controls and patients with intestinal-type GC. The frequency of an IL-10-592AA homozygote showing concomitant carriage of the HLA DRB1*0405-DQB1*0401 haplotype was significantly higher in patients with intestinal-type GC (chi(2) = 6.369, p = 0.0116, p(c) = 0.0464, OR = 2.43, 95% CI = 1.21-4.48). Our results suggest that the HLA class II and IL-10-592A/C polymorphisms synergistically affect the susceptibility to GC development of H. pylori-infected individuals in the Japanese population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19544559     DOI: 10.1002/ijc.24666

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  16 in total

Review 1.  Genetics and gastric cancer susceptibility.

Authors:  Yan Lu; Fang Lu; Sha Zeng; Suqing Sun; Li Lu; Lifeng Liu
Journal:  Int J Clin Exp Med       Date:  2015-06-15

2.  microRNAs as novel epigenetic biomarkers for human cancer.

Authors:  María Cortés-Sempere; Inmaculada Ibáñez de Cáceres
Journal:  Clin Transl Oncol       Date:  2011-06       Impact factor: 3.405

3.  Association between IL-4 -590C>T polymorphism and gastric cancer risk.

Authors:  Zihan Sun; Yuling Cui; Xiaohong Jin; Jing Pei
Journal:  Tumour Biol       Date:  2013-09-27

4.  Genetic association of osteopontin (OPN) and its receptor CD44 genes with susceptibility to Chinese gastric cancer patients.

Authors:  Yue Qiu; Yuan Hu; Zuo-Yang Zhang; Lei Ye; Fei-Hong Xu; Marion E Schneider; Xue-Ling Ma; Yi-Xin Du; Xian-Bo Zuo; Fu-Sheng Zhou; Gang Chen; Xu-Shi Xie; Yan Zhang; Hong-Zhen Xia; Ji-Feng Wu; Wei-Dong Du
Journal:  J Cancer Res Clin Oncol       Date:  2014-07-10       Impact factor: 4.553

Review 5.  The interleukin 10 -819C/T polymorphism and cancer risk: a HuGE review and meta-analysis of 73 studies including 15,942 cases and 22,336 controls.

Authors:  Zhibin Yu; Qing Liu; Chen Huang; Minghua Wu; Guiyuan Li
Journal:  OMICS       Date:  2013-04

6.  The -590C/T polymorphism in the IL-4 gene and the risk of cancer: a meta-analysis.

Authors:  Jie Zhang; Danli Xie; Huaibin Zhou; Runping Fan; Longyi Zhang; Cixiu Li; Sheng Jin; Qinghe Meng; Jianxin Lu
Journal:  Tumour Biol       Date:  2013-04-11

7.  The interleukin-10 promoter polymorphism rs1800872 (-592C>A), contributes to cancer susceptibility: meta-analysis of 16,785 cases and 19,713 controls.

Authors:  Qi Ding; Ying Shi; Bo Fan; Zhijiang Fan; Li Ding; Feng Li; Wenjian Tu; Xiaohua Jin; Jing Wang
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

8.  The roles of beta-adrenergic receptors in tumorigenesis and the possible use of beta-adrenergic blockers for cancer treatment: possible genetic and cell-signaling mechanisms.

Authors:  Khanh Vinh Quốc Lu'o'ng; Lan Thi Hoàng Nguyễn
Journal:  Cancer Manag Res       Date:  2012-12-18       Impact factor: 3.989

Review 9.  Interleukin (IL)-4 -590C>T polymorphism is not associated with the susceptibility of gastric cancer: An updated meta-analysis.

Authors:  Tie Wang; Lining Tian; Meizhuo Gao; Hongjiang Song; Yuzhe Wei; Yingwei Xue
Journal:  Ann Med Surg (Lond)       Date:  2016-05-18

10.  Genetic association between interluekin-4 rs2243250 polymorphism and gastric cancer susceptibility: evidence based on a meta-analysis.

Authors:  Chi Zhang; Jing-Yu Huang; Zi-Qi He; Hong Weng
Journal:  Onco Targets Ther       Date:  2016-04-20       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.